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Background: Jurisdictional drug information systems are being implemented in many regions around the world.
British Columbia, Canada has had a provincial medication dispensing record, PharmaNet, system since 1995. Little is
known about how accurately PharmaNet reflects actual medication usage.
Methods: This prospective, multi-centre study compared pharmacist collected Best Possible Medication Histories
(BPMH) to PharmaNet profiles to assess accuracy of the PharmaNet profiles for patients receiving a BPMH as part of
clinical care. A review panel examined the anonymized BPMHs and discrepancies to estimate clinical significance
of discrepancies.
Results: 16% of medication profiles were accurate, with 48% of the discrepant profiles considered potentially
clinically significant by the clinical review panel. Cardiac medications tended to be more accurate (e.g. ramipril was
accurate >90% of the time), while insulin, warfarin, salbutamol and pain relief medications were often inaccurate
(80–85% of the time). 1215 sequential BPMHs were collected and reviewed for this study.
Conclusions: The PharmaNet medication repository has a low accuracy and should be used in conjunction with
other sources for medication histories for clinical or research purposes. This finding is consistent with other, smaller
medication repository accuracy studies in other jurisdictions. Our study highlights specific medications that tend to
be lower in accuracy.Background
Medication errors are a common source of harm or po-
tential harm to patients [1,2]. Types of medication errors
include: medications inadvertently stopped (omission) or
restarted (commission), unwanted dosage or frequency
changes, and unintended drug interactions [3,4]. In a re-
view by Bates, prescription medication errors occurred
in up to 67% of patients being admitted to hospital with
11–59% of those being clinically important [5,6]. Poor
medication histories are a common source of medication
error [7] and better history taking, communication, and
electronic tools to support medication reconciliation,
such as community pharmacy databases are means by
which such errors can be reduced [2,8-12]. However,
there may be unintended consequences of using Infor-
mation Communication Technologies [13,14].* Correspondence: morgan@leadlab.ca
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reproduction in any medium, provided the orPharmaNet is British Columbia’s (BC) provincial re-
pository of medication dispensings from community
pharmacies. Established in 1995, it connects all commu-
nity pharmacies with the goal “to improve prescription
safety and support prescription claim processing” [15].
In 2007, it processed over 47 million prescription dis-
pensings. Authorized clinicians in community pharma-
cies, hospitals, emergency departments and medical
practices can access PharmaNet to view medication dis-
pensing records. Its use is widespread among pharma-
cists in BC as it is also the mechanism for billing for
community dispensings. A survey of BC physicians
reported that there was a perceived impact on prescrib-
ing practice in 20% of treatment decisions [16].A study
of 55 admission medication histories showed reviewing
PharmaNet helped identify drug therapy problems but
did not appear to improve medication histories [17].
PharmaNet has been used to answer research ques-
tions about prescription rates and adherence in BC
[18,19]. These studies assume the data in PharmaNet is
an accurate reflection of the medications being taken.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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43 congestive heart failure patients showed PharmaNet
to have “moderate to high” correlation to the compara-
tive medication event monitoring system [20], a 20 pa-
tient study in 2005 compared pharmacist taken Best
Possible Medication Histories (BPMHs) to PharmaNet
profiles and discovered 60% of patients had inaccurate
PharmaNet profiles [21]. PharmaNet was designed to
record the dispensing record of medications and may
not reflect usage of that medication. Other ambulatory
care electronic medical records have been shown to have
inaccurate medication lists [22,23]. Thus, clinicians may
turn to regional repositories as a source of truth. They
have been promoted to improve medication safety, one
of the higher sources of medication error. However,
small studies in other jurisdictions have also found low
accuracy rates of jurisdictional medication repositories
[20] suggesting that there is a real accuracy issue and
that it may not be unique to PharmaNet and thus fur-
ther work is needed in quantifying the gaps before
changes are made to improve accuracy and usability of
these systems. There may be unintended consequences
if clinicians and researchers assume jurisdictional medi-
cation records are accurate and they are not.
To explore this issue, we assessed the accuracy of BC’s
PharmaNet application, a well established jurisdictional
dispensing repository.
1. How accurate is a jurisdictional dispensing record,
such as PharmaNet, compared to BPMHs for
patients who receive BPMH as part of routine care?
2. What types of discrepancies are most common in a
jurisdictional repository?
3. What medications are most accurate and which are
frequently discrepant?
4. What is the rate of potentially significant
discrepancies amongst all discrepancies?Methods
Study participants
This six-month, multi-centre, prospective study engaged
pharmacists to collect sequential patient medication pro-
files. Joint University of Victoria and Vancouver Island
Health Authority ethics approval was received (#J2010-
104, 2010). Pharmacists were recruited through informa-
tion sessions at hospital pharmacy rounds and then
trained for the study. Patient eligibility criteria included
having clinical need for a BPMH and a recruited
pharmacist having access to the PharmaNet profile at
the time of the BPMH (terminals were readily available
at all sites). All patients who received a BPMH by a
recruited pharmacist during the study were included in
our analysis.Pharmacists documented the patient’s BPMH in a
Microsoft Access database as part of routine care and
were also asked to document any discrepancies discov-
ered between their BPMH and the patient’s PharmaNet
profile.a Discrepancy types were predefined: medication
missing on PharmaNet profile, medication erroneously
flagged as “current” on profile but not being taken,
medication missing the “current” flag on PharmaNet
Profile (NOTE: the current flag was an additional feature
provided in the vendor software used to display Pharma-
Net profiles), error in dose, error in route, error in fre-
quency, and unclear ingredient or instruction.Data extraction
Anonymized data was extracted from the pharmacist’s
BPMH electronic repository by one of the pharmacists
and provided to the researchers electronically as an excel
file. Data included: age, gender, current medication list,
medication discrepancies, and any comments provided
by the pharmacist pertaining to the documented medica-
tion discrepancies.Data analysis
Characteristics of the anonymized profiles and of the in-
dividual medication entries were tabulated. Descriptive
statistics were used in summarizing the data. For each
discrepancy type (from Bates et al.) [5], the overall num-
ber of discrepant medication entries was tabulated. Med-
ications were grouped by Anatomic Therapeutic Class
(ATC). Most accurate and most discrepant medication
classes were then identified.
A Clinical Study Panel was established with a clinical
pharmacist, a pharmacologist, and a family physician to
review a random sample of anonymized profiles with dis-
crepancies to estimate the potential risk of a significant
Adverse Drug Event (ADE). The Panel reviewed each pro-
file and estimated risk for potential ADE if all medications
were prescribed with the noted discrepancies. A Delphi
approach was used [24,25], modified for this study. Spe-
cifically, each panel member individually assessed the risk
of a potentially significant ADE. A potentially significant
ADE was defined as: requiring admission, increasing risk
of serious complication, deterioration of clinical condition
(e.g. infection, cancer), or worsening chronic illness (e.g.
depression) that could impact daily function within a two
month period. This definition is consistent with previ-
ously described scales [26].
A random sample of the patient profiles with discrep-
ancies was generated from within Microsoft Access to
ensure a margin of error of less than 5% at a 95% Confi-
dence Interval. Where consensus could not be reached,
an adjudicator (author, M.P.) reviewed the cases, the ra-
tionale for individual scores from the Panel, additional
Table 2 Discrepancies found in medications within
PharmaNet profiles as compared to BPMH by type
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discrepancies were potentially significant.
Profiles were grouped according to the number of
medication discrepancies they contained. For each group,
the number and rate of potentially significant ADEs was
tabulated and the medications most frequently associated
with potentially significant ADEs were identified.
Results
21 pharmacists from two hospitals were recruited to the
study. Pharmacists performed BPMHs at three locations
within the hospitals: Emergency Department, inpatient
wards, and pre-admission clinics as part of routine care.
Data was collected from January-May 2011. 1215 anon-
ymized patient medication profiles were sequentially col-
lected, containing 7791 medications. The average patient
age was 65.8 years, and 51.9% of patients were female.
There was an average of 6.4 medications per profile.
1024/1215 profiles (84.3%) were found to contain at least
one discrepancy. On average, discrepant profiles con-
tained 3.2 discrepancies. 3256/7791 (41.8%) of medica-
tions exhibited discrepancies (Table 1). Of the 1024 total
discrepant profiles, 84 were discrepant solely due to a
current flag related error. If these errors were removed
(as this specific feature was not part of the PharmaNet
specification), the overall rate of discrepant profiles
would fall from 84.3% to 77.4% (940/1215).
Medication missing from the Profile was the most fre-
quently documented discrepancy type (45%). Medica-
tions that could be purchased over the counter
accounted for the majority of these medication discrep-
ancies (up to 82%, although many of these would be
recommended by prescribers but purchased over the
counter). Medication listed on the Profile, but missing
the “current” flag was the second most commonly docu-
mented discrepancy with insulin, salbutamol and co-
deine being most frequently discrepant in this mannerTable 1 Summary of anonymized medication profiles
collected for this study
Study Sites 2 hospitals
Participating Pharmacists 21
Number of anonymized profiles
(male/female)
1215 (584/631)
Mean Age (range) Mean 65.8 +/− 14.8 yrs.
(Min 1, Max 98)
Total Medications entries documented 7791
Medications per patient 6.4
Medications with at least one
discrepancy (%)
3256 (41.8%)
Profiles with at least one
discrepancy (%)
1024 (84.3%)
Average # of discrepancies/profile
(95% CI)
3.2 (3.04-3.36)(26%). Discrepancies in dose or frequency accounted for
a further 25.05% of all recorded discrepancies. Table 2
summarizes discrepancies by type. Appendix A provides
a detailed list of the five most frequently discrepant
medication classes for each discrepancy type.
Table 3 lists the top five most accurate and five most
discrepant medication classes that were frequently dis-
pensed (i.e. used by more than 5% of study patients).
Ramipril was the most accurate medication in Pharma-
Net with discrepancies occurring in only 18/207 (8.7%)
appearances. Not surprisingly, artificial tears and ibupro-
fen, acetaminophen and acetylsalicylic acid were among
the most discrepant, largely because as over the counter
medications they rarely were captured in PharmaNet un-
less dispensed by a pharmacist. Of prescription medica-
tions, insulin frequently exhibited discrepancies (88.6%),
with discrepancies of dose and missing current flags
being most frequent. Warfarin’s high discrepancy rate
(82.5%) was largely due to dose and frequency errors.
Codeine & codeine combinations were routinely found
to be discrepant (78.4%) largely due to discrepancies in
frequency and missing current flags. Opiate agonists of
all types had discrepancies in 46.1% of entries (159/345)
with discrepancies of frequency and missing current
flags being most common.
A collection of medications including vitamins, creams
and other supplements (e.g. multivitamins, psyllium and
calcium carbonate) were documented more than any
other (427 times). Discrepancies were noted in 77.3% of
entries, and were largely due to the medications being ab-
sent from the profile, or in the case of creams, containing
ingredients that were not documented in PharmaNet.
The Panel reviewed 660/1024 anonymized medication
profiles with discrepancies (2.28% margin of error @Discrepancy type Number of
medication discrepancies
documented, by type






















Table 3 Five best and worst documented medications in
PharmaNet, determined by rate of discrepancy and being


























Codeine & combinations 78.43% (80/102)
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profiles (95.4%). 30 required arbitration. Potentially sig-
nificant ADEs occurred in 48.2% of reviewed cases (318/
660), and more frequently in patients with multiple
medications (Table 4). Discrepant medications most
commonly implicated in potentially serious cases
included: warfarin, salbutamol, insulin, codeine and
combinations, clonazepam and prednisone.Discussion
This study revealed a high number of discrepancies
(84.3%) between the gold standard Best Possible Medica-
tion History and medication profiles found in the Phar-
maNet provincial medication database. Several of these
discrepancies were expected, based on the scope ofTable 4 Number of profiles considered to have a
potentially serious ADE as determined by the clinical












0 191 (15.72%) n/a
1 278 (22.88%) 40/174 (22.99%)
2-3 417 (34.32%) 128/279 (45.88%)
4-5 192 (15.80%) 75/119 (63.02%)
6-9 108 (8.89%) 60/72 (83.33%)
10+ 29 (2.39%) 15/16 (93.75%)
Total 1215 (100%) 318/660 (48.18%)PharmaNet (e.g. absent over the counter, HIV, and hos-
pital dispensed medications); however, many were not.
The most common error was missing medications, fol-
lowed by medications that did not appear as active (or
“Current”) on the PharmaNet profile although they were
still being used. Almost half of profiles contained dis-
crepancies that were determined to be potentially clinic-
ally significant if not corrected (318/660). That is, if the
PharmaNet profile was considered accurate and was
solely used to direct prescribing, there was a significant
risk for medication errors that could lead to ADEs.
There are implications based on the findings in this
study that relate to use of PharmaNet for clinicians,
researchers and the PharmaNet program.
PharmaNet should be used by clinicians in conjunc-
tion with other clinical information (such as a patient
history), clinical judgment, and follow up to prevent po-
tential ADEs. The risk of significant error increases with
the number of medications a patient is taking. Clinicians
should focus attention on the common medication
classes listed in Table 5 due to the frequency with which
they are discrepant or absent from the PharmaNet pro-
file. Common and accurately recorded medications
(~90% accuracy in PharmaNet) tended to be cardiovas-
cular drugs (with the exclusion of ASA, 15% accuracy),
thyroid medication, and citalopram (Table 3).
For researchers using PharmaNet and potentially
other, similar medication repository data, they should be
aware of these limitations and not assume that Pharma-
Net accurately represents medication usage in a given
population. Studies have assessed expected completeness
of drug profiles, for example in Ontario [27]. However,
researchers should also assess accuracy of instructions
(if relevant) as these were also frequently inaccurate.
This study highlights that many patients are not taking
the medications as they were dispensed. This study has
shown several medications are often absent from the
profile (e.g. over the counter medications), and many are
used differently than was recorded at the time of dis-
pensing (e.g. dose and frequency discrepancies in war-
farin, insulin, opiate agonists). When employing
PharmaNet data to study medication usage, it would be
important to consider validating in PharmaNet the ac-
curacy of medications of interest.
For the PharmaNet program, which is undergoing en-
hancement [28], this study suggests that there may be
value in allowing trained clinicians (e.g. physicians, phar-
macists, nurse practitioners) to update patient profiles in
order to correct medication data when medication
changes are made or discrepancies are found (e.g. while
performing a BPMH). A current or regular medication
list is not available in the current PharmaNet design, but
could be considered for future updates. As many of the
discrepancies were medications that appeared expired




Artificial tears 98.44% (63/64) Be sure to ask about these over the counter
medications as they are very rarely found on the Profile.
Insulin 88.57% (93/105) Be sure to confirm the dose. In 30% of
Profiles containing Insulin’s the dose being
used will differ from that listed on PharmaNet.
Likewise, the “Current” flag will not appear in
30% of Insulin containing Profiles.
Ibuprofen, Acetaminophen and Acetylsalicylic acid
including combinations
86.07% (624/725) Be sure to ask about these over the counter
medications as they are very rarely found on the Profile.
Warfarin 82.46% (94/114) Expect a dose and/or frequency discrepancy in
nearly 60% of PharmaNet Profiles containing Warfarin.




Do not rely on the presence of the “Current”
flag to detect Codeine and Opiate Agonists on
the Profile; it is missing in 30% and 20% of cases, respectively.
Discrepancies in frequency are equally as
common.
Vitamins, creams and other supplements 77.28% (330/427) Be sure to ask about vitamins and supplements
as they are very rarely found on in PharmaNet.
In the case of compounded creams, it may be
necessary to contact the compounding
pharmacy in order to deduce the ingredients as
they are often not provided in PharmaNet.
Salbutamol & Related Drugs 68.15% (92/135) Do not rely on the presence of the “Current” flag to detect
Salbutamol and related drugs on the Profile; it is missing in
33% of cases.
Discrepancies in frequency occur in 17% of cases.
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flagging medications as “current” or “ongoing” may be
clinically relevant. Enhancements such as these would
increase the reliability of PharmaNet and thus improve
the efficiency of medication reconciliation during a
BPMH.
Findings here were similar to a smaller study per-
formed in Saskatchewan, where 39/50 (78%) of patients
had at least one discrepancy on their profile [20]. Also, a
study of 493 patients at Veteran Affairs found that their
integrated primary care medication record was accurate
in only 5.3% of patients [22], compared to a medication
history. This suggests that the findings are not unique to
BC and PharmaNet and other regional and jurisdictional
repositories may have similar accuracy rates.
This study has added to our knowledge of accuracy of
medication repositories by quantifying discrepancies in a
large, prospective study of patients whom are typically at
risk for medication errors. It has been able to describe,
by medication class, some of the more common discrep-
ancies as well as those medications that are accurately
described in PharmaNet. Other jurisdictions have or are
developing regionalized or national medication records
such as in Australia, the US [29] and the NHS. Where
these may rely on dispensing or prescribing informationto populate their repositories, similar accuracy issues
may exist.
Limitations
There are several limitations to this study. First, this was
not a randomized study of patients in BC; thus, the find-
ings in this study may not be applicable to the entire
population of the province. This patient population is
likely more complex and on more medications than
average. This study was completed within in BC with a
single medication repository (PharmaNet). Medication
profiles and discrepancy rates may be different in other
parts of the world and where other features are incorpo-
rated into the tools (e.g. reconciliation). However, other
studies suggest that there are significant error rates in
other repositories [22,23]. We did not perform chart
reviews when estimating the potential impact of the
observed discrepancies. Having a greater understanding
of the patients’ medical history would have allowed the
clinical study panel to be more precise in their estima-
tions of severity of potential ADEs. This would not have
allowed for the anonymous data collection and would
have limited the number of cases that were reviewed. It
is not typical that providers would rely solely on the
PharmaNet profile for prescribing without follow up,
Medications by ATC Class Number of
discrepancies
Medication missing
Acetylsalicylic Acid & Combinations 311
Uncoded vitamins, creams and other supplements 293
Acetaminophen & Combinations 206
Colecalciferol 92
Ibuprofen & Combinations 73
Medication missing “current” flag indicator
Salbutamol 45




Medication listed with inaccurate frequency












Discontinued medication listed as “current”
Zopiclone 5
Amitriptyline 4





Acetaminophen & Combinations 3
Clopidogrel 3
Medication listed with unclear ingredient
information or instructions
Warfarin 9





Medication listed with inaccurate route
Phenazopyridine 1
Uncoded vitamins, creams and other supplements 1
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ing or their symptoms were not being managed. Thus,
the construct for the Panel assessment, while useful in
this study, is somewhat theoretical.
Future work
This study was designed as a baseline study to assess the
current version of PharmaNet. PharmaNet is being
updated, with new features to be deployed in the coming
years. A repeat of this study once an enhanced Pharma-
Net is deployed and stabilized would provide evidence
to the impact of changes in the design of PharmaNet.
Comparative studies could be completed in other medica-
tion repositories. Further studies could assess the rates of
medication errors and potential ADEs, comparing patients
who receive BPMH on admission/discharge to hospital
and those who do not (i.e. those who rely more on the
PharmaNet profile). Controlled studies should be per-
formed that look at the addition and use of specific fea-
tures that support medication reconciliation. These could
discover what functions are needed (both social and tech-
nical) to improve accuracy of the repositories.
Conclusions
This study examined the accuracy of a provincial medi-
cation repository by comparing the electronic medica-
tion profile to pharmacist collected best possible
medication histories in patients who were deemed in
need of a BPMH. A significant number of these patients
(84%) had at least one discrepancy. 48% (2.28% error;
95% CI) of those patients had discrepancies that were
deemed potentially clinically significant. This study sug-
gests that using the electronic medication profile alone
is insufficient for completing a medication history and
must be reviewed in the context of other elements of
history from the patient and other health records. The
PharmaNet system was approximately 90% accurate in
describing ramipril, hydrochlorothiazide, atorvastatin,
levothyroxine sodium, and citalopram. Thus, could be
used effectively to help streamline the reconciliation
process for those medications. A medication history,
supported by PharmaNet should focus on confirming
the following medication classes: insulin, warfarin, co-
deine, salbutamol and ibuprofen/acetaminophen/acetyl-
salicylic acid, which were discrepant in 80–85% of cases.
As expressed in a PharmaNet bulletin, “PharmaNet is
not intended as a substitute for professional judgment.
Information on PharmaNet is not exhaustive and cannot
be relied upon as complete” [30].
Endnotes
aIn BC pharmacists review PharmaNet as part of a
BPMH.Appendix A
Top five medication discrepancies by discrepancy type,
summarized by ATC class*
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– Acetylsalicylic Acid & Combinations:
ACETYLSALICYLIC ACID and
ACETYLSALICYLIC ACID, COMB EXCL
PSYCHOLEPTICS
– Codeine & Combinations: CODEINE and
CODEINE, COMBINATIONS EXCL.
PSYCHOLEPTICS
– Ibuprofen & Combinations: IBUPROFEN and
IBUPROFEN, COMBINATIONS
– Salbutamol: SALBUTAMOL and SALBUTAMOL
AND OTHER DRUGS FOR OBSTRUCTIVE
AIRWAY DISEASES
– Insulins: INSULIN (HUMAN), INSULIN ASPART,
INSULIN DETEMIR, INSULIN GLARGINE,
INSULIN GLULISINE and INSULIN LISPRO
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